INTRODUCTION
The glutarimide moiety is present in a great number of molecules with a broad spectrum of pharmacological activity. The chemical structures of several glutarimide drugs are compared in Figure 1 . Cycloheximide is a powerful inhibitor of protein synthesis, which inhibits the transfer reaction (i.e. the release of deacylated t-RNA from P-site of ribosome) because of its specific binding interaction with a site on the 60 S ribosomal subunit (1, 2) . Among the novel antibiotics isolated from various species of Streptomyces, epiderstatin was shown to inhibit the mitogenic activity induced by epidermal growth factor (EFG) (3) .
It is interesting that many glutarimide drugs have been reported to possess anticancer activity. Sesbanimide is an alkaloid isolated from the seeds of Sesbania drummondii and S. punices, and it showed notable cytotoxicity against KB cells in vitro and potent inhibitory activity against P388 murine leukemia in vivo (4). Aminoglutethimide inhibits steroidogenesis at the aromatase sites, and is therefore used in therapy of metastatic breast cancer (5) . Another glutarimide derivative, Antineoplaston A10, is an agent originally isolated from human urine, which is remarkable for its anticancer activity and lack of toxicity (6) . It has been suggested that the A10 acts directly at the genomic level and alters the cellular responsiveness to steroid hormones (7) .
It should also be noted that many glutarimide derivatives have properties of partial agonists in the central nervous system (CNS). Their actions range from convulsive and analeptic (agonist) to anticonvulsive and hypnotic (antagonist). However, the mechanism of this action has not been elucidated (8) . Thalidomide was originally introduced as a sedative drug and later was found to cause disastrous teratogenicity. A number of investigations of the influence of thalidomide on embryonic development have been carried out, but its mode of action still remains uncertain (9) . At present, thalidomide is experiencing a renaissance as an experimental drug as a result of its ability to cure immunological disease (e.g. erythema nodosum leprosum, Behçet's syndrome and rheumatoid arthritis) (10) (11) (12) . Thus, thalidomide has become a promising agent for immunotherapy. It is applied in the prevention and treatment of graft-versus-host disease (GVHD) in allogeneic bone marrow transplantation (11) Glutarimide: a carrier transporting drug through cell membranes Summary It is suggested that glutarimide moiety (2,6-piperidinedione) with the intact imide group (OC-NH-CO) and substituted at α or β position in the ring, is acting as the carrier molecule (vector), which transports biologically active substituents (functional groups) through cell membranes. The results obtained from quantum chemical calculations and experimental studies indicate that structural features and physicochemical properties of glutarimide moiety are remarkably similar with those of uracil derivatives. Therefore, glutarimide drug may interact with specific receptors involved in transport of uracil and thymine nucleosides and it may easily cross biological membranes. © 2000 Harcourt Publishers Ltd and in the treatment of aphthous ulceration in HIV-positive patients (12) . Of particular interest is the fact that thalidomide inhibits the replication of latent HIV-1 virus in a monocytoid cell line and it selectively reduces tumor-necrosis factor-α (TNF-α) (13) .
Evidently, the presence of the glutarimide moiety in these drugs indicates some common property allowing for their activity in a cell. In order to cast more light on the mechanism of action of the glutarimide drugs, we have undertaken some quantum chemical calculations and experimental studies on the physicochemical properties of this molecule (14) (15) (16) (17) (18) (19) (20) .
HYPOTHESIS AND ITS SUPPORTING DATA
It is suggested that glutarimide moiety (2,6-piperidinedione) with the intact imide group (OC-NH-CO) and substituted at α or β position in the ring, is acting as the carrier molecule, which transports biologically active substituents through cell membranes. This is due to a striking similarity of the physicochemical properties of glutarimide and uracil derivatives. Thus, glutarimide moiety may interact with specific receptors involved in transport of uracil and thymine nucleosides and it may easily cross biological membranes, including nuclear membranes. It seems that glutarimide moiety may also cross a blood-brain barrier. Molecular ring of glutarimide is quite resistant to hydrolytic cleavage since it can be stabilized by formation of hydrogen bonding with biomolecules. The neutrality requirement is thought to be important for passage of a drug through cell membranes. Within a cell, however, the glutarimide compounds undergo hydrolysis to different ionic metabolites, being trapped, as they are unable to penetrate a membrane. These metabolites may exert a large variety of pharmacological activities.
The supporting data can be summarized as follows:
1. The geometry, electron density distribution along the O-C-N(H)-C-O imide skeleton, polarity of the exocyclic C=O and N-H bonds in glutarimide moiety, show close resemblance with those in uracil and thymine, as revealed by quantum chemical calculations and spectroscopic studies (14) (15) (16) . This indicates that glutarimide drugs may act as antagonist of uracil and thymine nucleosides in the electrostatic interaction and hydrogen bonding formation with biological molecules. Several investigators have also noted structural similarity of the imide core in glutarimide drugs and in pyrimidine bases (9,10,12). 2. Of particular interest is the fact that replacement of hydrogen atom in the OC-NH-CO group with the methyl or acetyl group results in complete loss of activity of cycloheximide (2) . Thus, the presence of the intact imide group is indispensable for the transport of glutarimide drugs through cell membranes. 3. A potentiometric study on interaction of glutarimide derivatives with metal ions, in aqueous solution, has shown that the stability constants of the complexes are similar to those of the corresponding metal complexes of uracil and thymine. It has been concluded that glutarimide and pyrimidine bases may have similar binding sites (17,18). 4. Molecular structures of the crystalline glutarimide complexes with some transition metal ions (19, 20) have shown remarkable similarity with the structures of the corresponding metal complexes of 1-methyluracil and 1-methylthymine. In all cases, the metal ion is bonded to the deprotonated nitrogen atom of the cyclic imide. This implies that glutarimide can be quite resistant to hydrolytic cleavage. A release of proton from nitrogen atom is followed by formation of a metal-nitrogen bond, and the cyclic structure of glutarimide moiety is preserved in these compounds. 
